Literature DB >> 12653378

Delayed diagnosis of cluster headache in African-American women.

S D Wheeler1, E J Carrazana.   

Abstract

The male-to-female ratio has fallen in cluster headache over the last several decades and is now 2.1:1. Unfortunately, women still are not diagnosed accurately. This lack of appropriate diagnosis appears related to the misconception that cluster headache rarely occurs in women. Compounding this misconception, there seems to be an ethnic bias. We report cluster headache in five African-American women in whom diagnosis was delayed due to gender, ethnicity, and, most importantly, an inability to make a correct diagnosis of cluster headache. Cluster headache diagnostic criteria are no different in men or women and have no ethnic boundaries. Clinical features such as disordered chronobiology and abnormal behavior often suggest the diagnosis. Migrainous features occur commonly in cluster headache and, when present, should not exclude the diagnosis. Likewise, neither race nor sex should exclude the diagnosis. The diagnosis of cluster headache is easily made by considering unilateral orbital, supraorbital or temporal location; short duration (15-180 minutes, untreated), and ipsilateral autonomic dysfunction involving the eye or nose.

Entities:  

Mesh:

Year:  2001        PMID: 12653378      PMCID: PMC2640610     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  9 in total

1.  Clinical caprices of histaminic cephalalgia.

Authors:  L L LOVSHIN
Journal:  Headache       Date:  1961-10       Impact factor: 5.887

2.  Male preponderance of cluster headache is progressively decreasing over the years.

Authors:  G C Manzoni
Journal:  Headache       Date:  1997-10       Impact factor: 5.887

3.  Gender ratio of cluster headache over the years: a possible role of changes in lifestyle.

Authors:  G C Manzoni
Journal:  Cephalalgia       Date:  1998-04       Impact factor: 6.292

4.  Accompanying symptoms of cluster attacks: their relevance to the diagnostic criteria.

Authors:  G Nappi; G Micieli; A Cavallini; C Zanferrari; G Sandrini; G C Manzoni
Journal:  Cephalalgia       Date:  1992-06       Impact factor: 6.292

5.  Cluster headache in the Republic of San Marino.

Authors:  R D'Alessandro; G Gamberini; G Benassi; G Morganti; P Cortelli; E Lugaresi
Journal:  Cephalalgia       Date:  1986-09       Impact factor: 6.292

6.  Hypothalamic activation in cluster headache attacks.

Authors:  A May; A Bahra; C Büchel; R S Frackowiak; P J Goadsby
Journal:  Lancet       Date:  1998-07-25       Impact factor: 79.321

Review 7.  Neuropeptides in migraine and cluster headache.

Authors:  L Edvinsson; P J Goadsby
Journal:  Cephalalgia       Date:  1994-10       Impact factor: 6.292

8.  Incidence of cluster headaches: a population-based study in Olmsted County, Minnesota.

Authors:  J W Swanson; T Yanagihara; P E Stang; W M O'Fallon; C M Beard; L J Melton; H A Guess
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

9.  Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.

Authors:  P J Goadsby; L Edvinsson
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

  9 in total
  3 in total

1.  Headache Literacy-A Definition and Theory to Help Improve Patient Outcomes of Diverse Populations and Ameliorate Headache and Headache Care Disparities.

Authors:  Larry Charleston; Michele Heisler
Journal:  Headache       Date:  2016-09-16       Impact factor: 5.887

2.  Phenotype of Cluster Headache: Clinical Variability, Persisting Pain Between Attacks, and Comorbidities-An Observational Cohort Study in 825 Patients.

Authors:  Carl H Göbel; Sarah Karstedt; Axel Heinze; Britta Koch; Hartmut Göbel
Journal:  Pain Ther       Date:  2021-05-04

3.  Ethnic differences in internal medicine referrals and diagnosis in the Netherlands.

Authors:  Loes C Lanting; Aart H Bootsma; Steven W J Lamberts; Johan P Mackenbach; Inez M A Joung
Journal:  BMC Public Health       Date:  2008-08-14       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.